Molecular mechanisms of glutamate-induced neurodegeneration

References

• Ashall F., Goate A.M. Role of the β-amyloid precursor protein in Alzheimer's disease. Trends in Biochemical Science 1994; 19: 42–46
   PubMed Web of Science ®Google Scholar
• Balazs R., Hack N., Jorgensen O.S., Cotman C.W. N-Methyl-D-Aspartate promotes the survival of cerebellar granule cells: pharmacological characterization. Neuroscience Letters 1989; 101: 241–246
   Google Scholar
• Benveniste H., Drejer J., Schousboe A., Diemer N.H. Elevation of the extracellular concentrations of glutamate and aspartate in rat hippocampus during transient cerebral ischemia monitored by intracerebral microanalysis. Journal of Neurochemistry 1988; 43: 1369–1374
   Google Scholar
• Brewer G.J., Cotman C.W. NMDA receptor regulation of neuronal morphology in cultured hippocampal neurons. Neuroscience Letters 1989; 99: 268–273
   PubMed Web of Science ®Google Scholar
• Buxbaum J.D., Oishi M., Chen H.I., Pinkas-Kramarski R., Jaffe E.A., Gandy S.E., Greengard P. Cholinergic agonists and Interleukin-1 regulate processing and secretion of the Alzheimer β/A4 amyloid protein precursor. Proceedings of the National Academy of Sciences, USA 1992; 89: 10075–10078
   PubMed Web of Science ®Google Scholar
• Choi D.W. Glutamate neurotoxicity in cortical cell culture is calcium dependent. Neuroscience Letters 1985; 58: 293–297
   PubMedGoogle Scholar
• Choi D.W. Glutamate neurotoxicity and diseases of the nervous system. Neuron 1988; 1: 623–634
   PubMed Web of Science ®Google Scholar
• Cohen M.L., Golde T.E., Usiak M.F., Younkin L.H., Younkin S.G. In situ hybridization of nucleus basalis neurons shows increased β amyloid mRNA in Alzheimer's disease. Proceedings of the National Academy of Sciences, USA 1988; 85: 1227–1231
   PubMedGoogle Scholar
• Del Bo R., Angeretti N., Lucca E., de Simoni M.G., Forloni G. Reciprocal control of inflammatory cytokines, IL-1 and IL-6, and β-amyloid production in cultures. Neuroscience Letters 1995; 188: 70–74
   Google Scholar
• Forloni G., de Micheu F., Giorgi S., Bendotti C., Angeretti N. Expression of amyloid precursor protein mRNAs in endothelial, neuronal and glial cells: modulation by interleukin-1. Brain Res. Mol. Brain Res. 1992; 16: 128–134
   PubMedGoogle Scholar
• Foster A.C. Physiology and pathophysiology of excitatory amino acid neurotransmitter systems in relation to Alzheimer's disease. Advances in Neurology 1990; 51: 97–101
   Google Scholar
• Drejer A., Fransden J., Schousboe A. Direct evidence that excitotoxicity in cultured neurons is mediated via N-methyl-D-aspartate (NMDA) as well as non-NMDA receptors. Journal of Neurochemistry 1989; 53: 297–299
   Google Scholar
• Goldgaber D., Harris H.W., Hla T., Maciag T., Donnelly R.J., Jacobsen J.S., Vitek M.P., Gajdusek D.C. Interleukin-1 regulates synthesis of amyloid β-protein precursor mRNA in human endothelial cells. Proceedings of the National Academy of Science USA 1989; 86: 7606–7610
   PubMed Web of Science ®Google Scholar
• Greenamyre J.T., Young A.B. Excitatory amino acids and Alzheimer's disease. Neurobiology of Aging 1989; 10: 593–602
   PubMed Web of Science ®Google Scholar
• Griffin W.S.T., Stanley L.C., Ling C., White L., MacLeod V., Perrot L.J., White C. L., III, Araoz C. Brain Interleukin-1 and S-100 immunoreactivity are elevated in Down Syndrome and Alzheimer's Disease. Proceedings of the National Academy of Sciences, USA 1989; 86: 7611–7615
   PubMed Web of Science ®Google Scholar
• Grilu M., Chiu J.-S., Lenardo M.J. NFκB and Rel: participants in a multiform transcriptional regulatory system. International Review of Cytology 1993; 143: 1–62
   Google Scholar
• Grilu M., Ribola M., Alberici A., Valerio A., Memo M., Spano P.F. Identification and characterization of a kB/rel binding site in the regulatory region of the amyloid precursor protein (APP) gene. Journal of Biological Chemistry 1995; 270: 26774–26777
   Google Scholar
• Higgins G.A., Oyler G.A., Neve R.L., Chen K.S., Gage F.H. Differential regulation of amyloid-β-protein mRNA expression within hippocampal neuronal subpopulations in Alzheimer's disease. Proceedings of the National Academy of Sciences, USA 1988; 85: 1297–1301
   Google Scholar
• Ishii T., Kametani F., Haga S., Sato M. The immunohistochemical demonstration of subsequences of the precursor of the amyloid A4 protein in senile plaques in Alzheimer's disease. Neuropathology and Applied Neurobiology 1989; 15: 135–147
   PubMedGoogle Scholar
• Johnson S.A., McNeill T., Cordell B., Finch C.E. Relation of neuronal APP-751/APP-695 mRNA ratio and neuritic plaque density in Alzheimer's disease. Science 1990; 248: 854–857
   PubMedGoogle Scholar
• Kang S-M., Tran A-C., Grilli M., Lenardo M.J. NFkB subunit regulation in non-transformed CD4+ T lymphocytes. Science 1992; 256: 1452–1456
   PubMed Web of Science ®Google Scholar
• Koh J., Palmer E., Lin A., Cotman C.W. Activation of metabotropic glutamate receptor attenuates N-methyl-D-aspartate neurotoxicity in cortical cultures. Proceedings of the National Academy of Sciences, USA 1991; 88: 9431–9435
   Google Scholar
• Koh J-Y., Yang L.L., Cotman C.W. β-amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Research 1990; 533: 315–320
   PubMed Web of Science ®Google Scholar
• Liou H.-C., Baltimore D. Regulation of the NF-κB/rel transcription factor and IkB inhibitor system. Current Opinion in Cell Biology 1993; 5: 477–487
   PubMed Web of Science ®Google Scholar
• Mandelkow E-M., Mandelkow E. Tau as a marker for Alzheimer's disease. Trends in Biochemical Science 1993; 18: 480–483
   PubMedGoogle Scholar
• Mattson M.P., Cheng B., Culwell A.R., Esch F.S., Lieberburg I., Rydel R.E. Evidence for excitoprotective and intxaneuronal calcium-regulating roles for secreted forms of the β-amyloid precursor protein. Neuron 1993; 10: 243–254
   PubMed Web of Science ®Google Scholar
• Mattson M.P., Cheng B., Davis D., Bryant K., Leiberburg J., Rydel R. b-amyloid peptides destabilize calcium homeostasis and render human cortical neurons vulnerable to excitotoxicity. Journal of Neuroscience 1992; 12: 376–389
   PubMed Web of Science ®Google Scholar
• McDonald J.W., Johnston M.V. Physiological and pathophysiological roles of excitatory amino acids during central nervous system development. Brain Research Review 1990; 15: 41–70
   PubMed Web of Science ®Google Scholar
• McGeer P.L., Rogers J. Antinflammatory agents as a therapeutic approach to Alzheimer's disease. Neurology 1992; 42: 447–449
   PubMed Web of Science ®Google Scholar
• Meda L., Cassatella M.A., Szendrei G.I., Otvos L., Baron P., Villalba M., Ferrari D., Rossi F. Activation of microglial cells by β-amyloid protein and interferon-γ. Nature 1995; 374: 647–650
   PubMed Web of Science ®Google Scholar
• Nakanishi S. Metabotropic glutamate receptors: synaptic transmission, modulation, and plasticity. Neuron 1994; 13: 1031–1037
   PubMed Web of Science ®Google Scholar
• Neve R.L., Finch E.A., Dawes L.R. Expression of the Alzheimer's amyloid precursor gene transcripts in the human brain. Neuron 1988; 1: 667–669
   Google Scholar
• Pizzi M., Ribola M., Valerio A., Memo M., Spano P.F. Various Ca2+ entry blockers prevent glutamate-induced neurotoxicity. European Journal of Pharmacology 1991; 209: 169–173
   Google Scholar
• Pizzi M., Fallacara C., Arrighi V., Memo M., Spano P.F. Attenuation of excitatory amino acid toxicity by metabotropic glutamate receptor agonists and aniracetam in primary cultures of cerebellar granule cells. Journal of Neurochemistry 1993; 61: 683–689
   PubMed Web of Science ®Google Scholar
• Pizzi M., Valerio A., Arrighi V., Belloni M., Alberici A., Spano P.F., Memo M. Anti-sense strategy unravels tau proteins as molecular risk factors for glutamate-induced neurodegeneration. Molecular Cell Neurobiology 1994; 14: 569–578
   Google Scholar
• Pizzi M., Valerio A., Arrighi V., Galu P., Belloni M., Ribola M., Alberici A., Spano P.F., Memo M. Inhibition of glutamate-induced neurotoxicity by a tau antisense oligonucleotide in primary culture of rat cerebellar granule cells. European Journal of Neuroscience 1995; 7: 1603–1613
   Google Scholar
• Pomara N., Singh R., Deptula D., Chou J. C-Y., Schwartz M.B., Le Witt P.A. Glutamate and other CSF amino acids in Alzheimer's disease. American Journal of Psychiatry 1992; 149: 251–254
   PubMedGoogle Scholar
• Querfurth H.W., Wijsman E.M., George-Hyslop P.H., Selkoe D.J. βAPPmRNA transcription is increased in cultured fibroblasts from the familial Alzheimer's disease-1 family. Molecular Brain Research 1995; 28: 319–337
   PubMedGoogle Scholar
• Randall R.D., Thayer S.A. Glutamate-induced calcium transient triggers delayed calcium overload and neurotoxicity in rat hippocampal neurons. Journal of Neuroscience 1992; 12: 1882–1895
   PubMed Web of Science ®Google Scholar
• Rashid N.A., Cambray-Deakin M.A. N-Methyl-D-Aspartate effects on the growth, morphology and cytoskeleton of individual neurons in vitro. Developments in Brain Research 1992; 67: 301–308
   Google Scholar
• Rothman S.M., Olney J.W. Excitotoxicity and the NMDA receptors. Trends in Neuro Science 1988; 10: 299–302
   Google Scholar
• Salbaum J.M., Weidemann A., Lemaire H., Masters C.L., Beyreuther K. The promoter of Alzheimer's disease amyloid A4 precursor gene. EMBO Journal 1988; 7: 2807–2813
   PubMed Web of Science ®Google Scholar
• Selkoe D.J. Normal and abnormal biology of the β-amyloid precursor protein. Annual Review of Neuroscience 1994; 17: 489–517
   PubMed Web of Science ®Google Scholar
• Siliprandi R., Liparttti M., Fadda E., Sautter J., Manev H. Activation of the glutamate metabotropic receptor protects retina against N-methyl-D-aspartate toxocity. European Journal of Pharmacology 1992; 219: 173–174
   Google Scholar
• Excitatory Amino Acids. Fidia Res. Found. SymSeries, R.P. Simon. Thieme Medical Publisher, New York 1992; vol. 9
   Google Scholar
• Trejo J., Massamiri T., Deng T., Dewji N.N., Bayney R.M., Brown J.H. A direct role for protein kinase C and the transcription factor Jun/AP1 in the regulation of the Alzheimer's β-Amyloid Precursor Protein gene. Journal of Biological Chemistry 1994; 269: 21682–21690
   PubMed Web of Science ®Google Scholar
• Tymianski M., Charlton M.P., Carlen P.L., Tator C.H. Source specificity of early calcium neurotoxicity in cultured embrionic spinal neurons. Journal of Neuroscience 1993; 13: 2085–2104
   PubMed Web of Science ®Google Scholar
• Valerio A., Alberici A., Paterlini M., Grilli M., Galu P., Pizzi M., Memo M., Spano P.F. Opposing regulation of amyloid precursor protein by ionotropic and metabotropic glutamate receptors. Neuro Report 1995; 6: 1317–1321
   Google Scholar
• Yoshikawa K., Aizawa T., Hayashi Y. Degeneration in vitro of postmitotic neurons overex-pressing the Alzheimer amyloid protein Precursor. Nature 1992; 359: 64–67
   PubMedGoogle Scholar